The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE exposure during spaceflight.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionInnate Immune Signaling Activated by MDR Bacteria in the AirwayTargeting bacterial adherence inhibits multidrug-resistant Pseudomonas aeruginosa infection following burn injuryPrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.New perspectives in the management of Pseudomonas aeruginosa infections.Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.New horizons in hospital acquired pneumonia in older people.Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.Structural investigation of human S. aureus-targeting antibodies that bind wall teichoic acid
P2860
Q26748155-91FCA381-5AEF-48D4-835F-EA71A056CE30Q34596138-BB85C393-F5C7-4F50-B2F6-2C75B77C31E3Q35203060-A21677AD-0EC0-4182-9F87-77E71751E34EQ36238031-F49E01AA-D279-4BB0-8C0B-67888C4F8C2CQ36422470-22F12E3B-27D8-40C9-8A99-6761E06107CCQ37518925-6E14A1C6-0949-45DA-9151-A624CC8E8F05Q37713295-5AE2A222-169F-493F-AEC4-29CDABE39CBDQ38210319-D159A1D4-6BE4-4841-8F6E-D16E1C456107Q38243221-54FFCCC8-C8FD-4BCA-B7C9-27076F46C251Q38833703-DCF1EB51-3ECB-43AF-80E4-C63E8EC0ABB5Q40279983-A8DA30E7-DD61-43BB-9601-5571806BA1E6Q40644061-BDC365A5-834C-4A27-9424-EC189A51BEC0Q58709450-45CD1CD4-780C-48AA-8759-A852DDD9C8AD
P2860
The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@ast
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@en
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@nl
type
label
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@ast
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@en
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@nl
prefLabel
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@ast
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@en
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@nl
P2093
P2860
P921
P1433
P1476
The anti-Pseudomonas aeruginos ...... ditive effects with meropenem.
@en
P2093
Louis Fauconnier
Marieke Mathieu
Michael Rudolf
Oliver Rutschi
Stefanie Fas
Thomas Secher
P2860
P304
P356
10.1371/JOURNAL.PONE.0073396
P407
P577
2013-09-02T00:00:00Z